Tinnitus: algorithm of diagnostics and clinical management

Boiko N.V.

doi:https://doi.org/10.17116/jnevro20171179188-93

Close metadata

Recommended articles:

Difficulties in lifetime diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27

The use of artificial intelligence in modern dentistry in the Russian Federation. Stomatology. 2024;(5):42-45

Quality assessment of health care delivery to patients with sexually transmitted infections in dermatovenereological institutions of Moscow according to medical records analysis. Russian Journal of Clinical Dermatology and Venereology. 2024;(5):503-509

Tinnitus features and masking in patients with normal hearing and with high frequency hearing loss. Russian Bulletin of Otorhinolaryngology. 2024;(5):4-9

Clinical case of auricular gouty tophi. Russian Bulletin of Otorhinolaryngology. 2024;(6):80-84

Detection of mpox virus by enzyme immunoassay in a no-instrumental format and after its inactivation with formaldehyde. Molecular Genetics, Microbiology and Virology. 2024;(4):49-53

Laboratory diagnostics of monkeypox: basic methods and prospects for new developments. Laboratory Service. 2024;(4):57-64

Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medicine. 2025;(1):109-114

Results of the All-Russian consensus conference on complications in bariatric surgery. Endoscopic Surgery. 2025;(1):15-24

X-ray endoscopic classification of aspiration syndrome. Endoscopic Surgery. 2025;(1):31-37

Abstract:

Hearing of sound, or tinnitus, can be a symptom of different diseases. The differential diagnosis should be based on the identification of subgroups with confirmed causes of the disease. Subjective and objective tinnitus groups should be isolated. Objective tinnitus can be vascular or muscular. In making a diagnosis of tinnitus, it is important to know its characteristics, laterality, circumstances of onset, duration, comorbidity with other symptoms: headache, hearing decline, dizziness, depression, etc. Urgent diagnostic and treatment measures are needed after the identification of «red flags»: acute pulsatile tinnitus, in particular after the brain injury, combination of tinnitus with acute hearing loss and depression.

Keywords:

tinnitus

diagnosis

EGb 761

Authors:

Boiko N.V.

Rostov State Medical University, Ministry of Health of Russia, Rostov-on-Don, Russia

Close metadata

References:

Jastreboff PJ. Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res. 1990;8:221-254. https://doi.org/10.1016/0168-0102(90)90031-9
Langguth B, Kreuzer PM, Kleinjung T, Ridder DD. Tinnitus: causes and clinical management. Lancet Neurol. 2013;12:920-930. https://doi.org/10.1016/s1474-4422(13)70160-1
Espinosa-Sánchez JM, Heitzmann-Hernández T, López-Escámez JA. [Pharmacotherapy for tinnitus: much ado about nothing] [Article in Spanish]. Rev Neurol. 2014;59(4):164-174.
Kryukov AI, Kunel¢skaya NL, Arablinsky AV, Yanyushkina ES. Objective Tympanophonia. Case report. Vestnik otorinolaringologii. 2009;2:62-63. (In Russ.).
Boiko NV, Batueva VA. Epistaxis from posttraumatic aneurysm of the internal carotid artery. Rossiyskaya rinologiya. 2016;24(2):30-34. (In Russ.). https://doi.org/10.17116/rosrino201624130-34
Madani G, Connor SEJ. Imaging in pulsatile tinnitus. Clinical Radiology. 2009;64(3):319-328. https://doi.org/10.1016/j.crad.2008.08.014
Kolesnikov VN, Boiko NV, Pisarenko EA. Surgical removal of tympanic paragangliomas with sound-transmitting structures of the middle ear preservation. Rossiiskaya otorinolaringologiya. 2011;55(6):69-77. (In Russ.).
Kouzaki H, Fukui J, Shimizu T. To report the safe management and treatment of a catecholamine-secreting tympanicum glomus tumour. J Laryngol Otol. 2008;122(12):1377-1380. https://doi.org/10.1017/s0022215108001801
Somasundar P, Krouse R, Hostetter R, Vaughan R, Covey T. Paragangliomas? A decade of clinical experience. J Surg Oncol. 2000;74(4): 286-290. https://doi.org/10.1002/1096-9098(200008)74:4<286::aid-jso9>3.0.co;2-c
Lee K, Chang J, Park S, Im GJ, Choi HJ, Kim JH, Kim H-J. Bilateral muscular tinnitus due to myoclonus of extrinsic auricular muscles. Auris Nasus Larynx. 2014. Available online: www.elsevier.com/locate/anl https://doi.org/10.1016/j.anl.2014.10.009
Zadikoff C, Lang AE, Klein C. The ‘essentials’ of essential palatal tremor: a reappraisal of the nosology. Brain. 2006;129(4):832-840. https://doi.org/10.1093/brain/awh684
Sinclair CF, Gurey LE, Blitzer A. Palatal myoclonus: algorithm for management with botulinum toxin based on clinical disease characteristics. Laryngoscope. 2014;124(5):1164-1169. https://doi.org/10.1002/lary.23485
MacDonald JT. Objective Tinnitus Due to Essential Palatal Tremor in a 5-Year-Old. Pediatric Neurology. 2006;36(3):175-176. https://doi.org/10.1016/j.pediatrneurol.2006.10.009
Godeiro-Junior C, Felicio AC, Felix EP, Manzano GM, Silva SM, Borges V, Ferraz HB, Barsottini OGP. Moving ear syndrome: the role of botulinum toxin. Mov Disord. 2008;23:122-124. https://doi.org/10.1002/mds.21773
Penney SE, Bruce IA, Saeed SR. Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature. Journal of Neurology. 2006;253(7):857-860. https://doi.org/10.1007/s00415-006-0039-9
Anis MM, Pollak N. Treatment of palatal myoclonus with botulinum toxin injection. Case Rep in Otolaryngol. 2013;231505. https://doi.org/10.1155/2013/231505
Sinclair CF, Gurey LE, Blitzer A. Palatal myoclonus: algorithm for management with botulinum toxin based on clinical disease characteristics. Laryngoscope. 2014;124(5):1164-1169. https://doi.org/10.1002/lary.23485
Wan TK, Chen JT, Wang PC. EMG-guided salpingopharyngeus Botox injection for palatal myoclonus. B-ENT. 2013;9(1):67-69.
Lee K, Chang J, Park S, Im GJ, Choi HJ, Kim JH, Kim H-J. Bilateral muscular tinnitus due to myoclonus of extrinsic auricular muscles. Auris Nasus Larynx. 2014. Available online: www.elsevier.com/locate/anl https://doi.org/10.1016/j.anl.2014.10.009
Boiko NV. Objective tinnitus due to myoclonus of auricular muscles. Vestnik otorinolaringologii. 2017;82(3):80-83. (In Russ.).
Boiko NV. Vertigo in therapeutist’s practice. Lechashhii vrach. 2010;4:86. (In Russ.).
Boiko NV, Kunel’skaya NL. The phenomenon of mobile third window. Vestnik otorinolaringologii. 2016;81(3):69-74. (In Russ.). https://doi.org/10.17116/otorino201681369-74
Stagnieva IV, Boyko NV. Headache and facial pain in rhinosinusitis. Medicinskij vestnik Juga Rossii. 2014;3:55-59. (In Russ.).
Wyrick D, Smith SD, Dassinger MS. Traumatic carotid — cavernous fistula presenting as massive epistaxis. J of Ped Surg. 2013;48:883-886. https://doi.org/10.1016/j.jpedsurg.2013.01.041
Erickson BP, Johnson TE. A 32-year-old man with delayed onset, post-travmatic proptosis and diplopia. The J of Emer Med. 2014;46(4):475-478. https://doi.org/10.1016/j.jemermed.2013.09.015
Miller NR. Diagnosis and management of dural carotid-cavernous sinus fistulas. Neurosurg Focus. 2007;23(5):13. https://doi.org/10.3171/foc-07/11/e13
Gemmete JJ, Ansari SA, Gandhi DM. Endovascular techniques for treatment of carotid-cavernous fistula. J Neuroophthalmol. 2009;29:62-71. https://doi.org/10.1097/wno.0b013e3181989fc0
Nadarajah J, Madhusudhan KS, Yadav AK, Chandrashekhara SH, Kumar A, Gupta AK. MR imaging of cavernous sinus lesions: Pictorial review. J of Neurorad. 2015;42:305-319. https://doi.org/10.1016/j.neurad.2015.04.010
Cohen JE, Moscovici S, Gomori JM, Eliashar R, Weinberger J, Itshayek E. Selective endovascular embolization for refractory idiopathic epistaxis is a safe and effective therapeutic option: Technique, complications, and outcomes. J of Clin Neurosci. 2012;19:687-690. https://doi.org/10.1016/j.jocn.2011.08.019
Shcherbakova YaL. Pharmakotherapy of sensorineural hearing loss with tinnitus. Rossiiskaya otorinolaringologiya. 2014;73(6):140-144. (In Russ.).
Syroezhkin FA, Nikitin NI, Dvorjanchikov VV, Golovanov, Morozova MV, Letjagin AI. Sovremennye predstavlenija ob ushnom shume v aspekte nejroplastichnosti: perspektivy primenenija sluhovoj trenirovki. Vestnik rossijskoj voenno-medicinskoj akademii. 2015;51(3):94-98. (In Russ.).
Ringing ears: the neuroscience of tinnitus. In: Eggermont J.J., Larry Roberts L., edds. Frontiers Research Topics. Frontiers Media SA. 2012. https://doi.org/10.3389/978-2-88919-039-3
Aiken CB. Neuroprotection in Bipolar Depression. In: Brain Protection in Schizophrenia, Mood and Cognitive Disorders. 2010;451-483. https://doi.org/10.1007/978-90-481-8553-5_15
Ahlemeyer B, Krieglesytain J. Neuroproсtetive effects of Gingko biloba. Cell Mol Life Sci. 2003;60:1779-1792. https://doi.org/10.1007/s00018-003-3080-1
Boĭko AN, Lebedeva AV, Shchukin IA, Soldatov MA, Ismailov AM, Shikhkerimov RK, Otcheskaia OV, Khozova AA. Possibilities of medical correction of moderate cognitive impairment. Zh Nevrol Psikhiatr Im. S.S. Korsakova. 2013;113(2):28-32. (In Russ.).
Kaschel R. Gingko biloba: specificity of neuropsychological improvement — a selective review in search of differential effects. Hum Psychopharmacol. 2009;24:5:345-370. https://doi.org/10.1002/hup.1037
Chutko LS, Surushkina SIu, Rozhkova AV, Nikishena IS, Iakovenko EA. Asthenic syndrome in patients with burnout syndrome. Zh Nevrol Psikhiatr Im. S.S. Korsakova. 2013; 113(11):22-26. (In Russ.).
Kuznetsova SM, Shulzhenko DV. Gingko Biloba Extract in the Treatment Strategies for Chronic Cerebrovascular Diseases. Mezhdunarodnyj nevrologicheskij zhurnal. 2015;72(2):109-115. (In Russ.).
Kunelskaya NL, Kamchatnov PR, Gulieva AE. Therapeutic policy in cochleovestibular disorders in the presence of cerebral circulatory insufficiency. Vestnik otorinolaringologii. 2008;1:47-50. (In Russ.).
Choi SJ, Kim SW, Lee JB, Lim HJ, Kim YJ, Tian C, So HS, Park R, Choung Y-H. Gingko biloba extracts protect auditory hair cells from cisplatin-induced ototoxicity by inhibiting perturbation of gap junctional intercellular communication. Neuroscience. 2013;244:49-61. https://doi.org/10.1016/j.neuroscience.2013.04.001
Dias MA, Sampaio AL, Venosa AR, Meneses Ede A, Oliveira CA. The chemopreventive effect of Gingko biloba extract 761 against cisplatin ototoxicity: a pilot study. Int Tinnitus J. 2015;19(2):12-19. https://doi.org/10.5935/0946-5448.20150003
Tziridis K, Korn S, Ahlf S, Schulze H. Protective effects of Gingko biloba extract EGb 761 against noise trauma-induced hearing loss and tinnitus development. Neural Plast. 2014;2014:427298. https://doi.org/10.1155/2014/427298
Krauss P, Tziridis K, Buerbank S, Schilling A, Schulze H.Therapeutic Value of Gingko biloba Extract EGb 761® in an Animal Model (Meriones unguiculatus) for Noise Trauma Induced Hearing Loss and Tinnitus. PLoS One. 2016;11(6):0157574. https://doi.org/10.1371/journal.pone.0157574
Koo JW, Chang MY, Yun SC, Kim TS, Kong SK, Chung JW, Goh EK. The efficacy and safety of systemic injection of Gingko biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial. Eur Arch Otorhinolaryngol. 2016;273(9): 2433-2441. https://doi.org/10.1007/s00405-015-3821-4
Tan J, Peng H. Clinical analysis of Gingko biloba injection combined with traditional therapy in treatment of explosive deafness. [Article in Chinese] Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2015;33(4):279-281.
Morgenstern C, Biermann E. The efficacy of Gingko special extract EGb 761 in patients with tinnitus. Int J Clin Pharmacol Ther. 2002;40(5):188-197. https://doi.org/10.5414/cpp40188
Birks J, Grimley Evans J. Gingko biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2007;2:CD003120. https://doi.org/10.1002/14651858.cd003120.pub2
Ihl R, Bunevicius R, Frölich L, Winblad B, Schneider LS, Dubois B, Burns A, Thibaut F, Kasper S, Möller HJ. World Federation of Societies of Biological Psychiatry guidelines for the pharmacological treatment of dementias in primary care. Int J Psychiatry Clin Pract. 2015;19(1):2-7. https://doi.org/10.3109/13651501.2014.961931
Нoerr R, Bachinskaya N, Ihl R. Alleviating neuropsychiatric symptoms in dementia: the effects of Gingko biloba extract EGb 761. Findings from a randomized controlled trial. Neuropsychiatric Disease and Treatment. 2011;7:209-215. https://doi.org/10.2147/ndt.s18741
Gauthier S, Schlaefke S. Efficacy and tolerability of Gingko biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials. Clin Interv Aging. 2014;9:2065-2077. https://doi.org/10.2147/CIA.S72728
von Gunten A, Schlaefke S, Überla K. Efficacy of Gingko biloba extract EGb 761 in dementia with behavioural and psychological symptoms: A systematic review. World J Biol Psychiatry. 2016;17(8):622-633. https://doi.org/10.3109/15622975.2015.1066513
DeFeudis F, Drieu K. Gingko biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets. 2000;1:1:25-58. https://doi.org/10.2174/1389450003349380